A . Methanobrevibacter P= 0.96 ,CI=95 %

1
A. Methanobrevibacter P= 0.96,CI=95% B. Sulphur reducing bacteria P= 0.88,CI=95% Fig.S1. Real-time analysis of population of (A) Methanobrevibacter in Healthy vs E. histolytica positive samples.(B) Sulphur reducing bacteria in Healthy vs E. histolytica positive samples. P value =.05 or below was considered significant. CI stands for confidence interval.

description

A . Methanobrevibacter P= 0.96 ,CI=95 %. B. Sulphur reducing bacteria P= 0.88 ,CI=95%. - PowerPoint PPT Presentation

Transcript of A . Methanobrevibacter P= 0.96 ,CI=95 %

Page 1: A . Methanobrevibacter P= 0.96 ,CI=95 %

A. Methanobrevibacter P= 0.96,CI=95%

B. Sulphur reducing bacteria P= 0.88,CI=95%

Fig.S1. Real-time analysis of population of (A) Methanobrevibacter in Healthy vs E. histolytica positive samples.(B) Sulphur reducing bacteria in Healthy vs E. histolytica positive samples. P value =.05 or below was considered significant. CI stands for confidence interval.

Detection, Burden, and Impact...2021/03/19  · 95% CI 0.594-1.335) and staff (IRR = 1.015, 95% CI 0.754-1.365) (Figure). Methods : Retrospective cohort study of 537,336 students and

Detection, Burden, and Impact...2021/03/19  · 95% CI 0.594-1.335) and staff (IRR = 1.015, 95% CI 0.754-1.365) (Figure). Methods : Retrospective cohort study of 537,336 students and

Opzet studie en determinanten van longfunctie en astma...FEV 1, z-score (95% CI) Zwangerschapsduur (wkn) Asthma, odds ratio (95% CI) P trend

Opzet studie en determinanten van longfunctie en astma...FEV 1, z-score (95% CI) Zwangerschapsduur (wkn) Asthma, odds ratio (95% CI) P trend

Integrative Medicine Use in Advanced Cancer › wp-content › uploads › CA… · Cancer Treatment Dietary Supplement use during or aer Cancer Treatment n (%)£ OR (95%CI) OR (95%CI)

Integrative Medicine Use in Advanced Cancer › wp-content › uploads › CA… · Cancer Treatment Dietary Supplement use during or aer Cancer Treatment n (%)£ OR (95%CI) OR (95%CI)

Effects of Fibrates in Kidney Disease - CORE · 2017. 2. 1. · 95% CI: 0.54 to 0.89; p 0.004) and cardiovascular death (RR: 0.60; 95% CI: 0.38 to 0.96; p 0.03) but not all-cause

Effects of Fibrates in Kidney Disease - CORE · 2017. 2. 1. · 95% CI: 0.54 to 0.89; p 0.004) and cardiovascular death (RR: 0.60; 95% CI: 0.38 to 0.96; p 0.03) but not all-cause

hyperbilirubinemia guidelines in Ontario: A population ... · decrease in jaundice-related ED visits (RR 0.79, 95% CI 0.64-0.96), but no statistically significant difference in phototherapy

hyperbilirubinemia guidelines in Ontario: A population ... · decrease in jaundice-related ED visits (RR 0.79, 95% CI 0.64-0.96), but no statistically significant difference in phototherapy

SELECTED ABSTRACTS - American Neurotology Society · private insurance (OR: 2.4 [95% CI: 1.10-5.04]) and Medicare (OR: 7.6 [95% CI: 1.9-30.3]) was associated with higher levels of

SELECTED ABSTRACTS - American Neurotology Society · private insurance (OR: 2.4 [95% CI: 1.10-5.04]) and Medicare (OR: 7.6 [95% CI: 1.9-30.3]) was associated with higher levels of

RESEARCH ARTICLE Open Access Endovascular coiling ......Glasgow Outcome Scale (OR, 2.38; 95% CI, 1.33–4.26) and Modified Rankin Scale (OR, 2.83; 95% CI, 1.42–5.63) when compared

RESEARCH ARTICLE Open Access Endovascular coiling ......Glasgow Outcome Scale (OR, 2.38; 95% CI, 1.33–4.26) and Modified Rankin Scale (OR, 2.83; 95% CI, 1.42–5.63) when compared

Pesticides, Agent Orange and Parkinson's Disease · Pesticides, Agent Orange and Parkinson's Disease Jeff Bronstein MD,PhD ... Case Control OR* 95% CI Case Control OR* 95% CI Ziram

Pesticides, Agent Orange and Parkinson's Disease · Pesticides, Agent Orange and Parkinson's Disease Jeff Bronstein MD,PhD ... Case Control OR* 95% CI Case Control OR* 95% CI Ziram

2 0 1 7 Y O U T H R I S K B E H A V I O R S U R V E Y R E ...€¦ · A's B's C's D's/F's Significant Association* Health Risk Behavior % 95% CI† % 95% CI % 95% CI % 95% CI QN30:

2 0 1 7 Y O U T H R I S K B E H A V I O R S U R V E Y R E ...€¦ · A's B's C's D's/F's Significant Association* Health Risk Behavior % 95% CI† % 95% CI % 95% CI % 95% CI QN30:

Research Paper Immune checkpoint inhibitor (ICI ...95% CI 1.29-1.55, p < 0.0001), PFS (HR 0.83, 95% CI 0.74-0.94, p = 0.003)and OS (HR 0.90, 95% CI 0.82-0.98, p = 0.02) in patients

Research Paper Immune checkpoint inhibitor (ICI ...95% CI 1.29-1.55, p < 0.0001), PFS (HR 0.83, 95% CI 0.74-0.94, p = 0.003)and OS (HR 0.90, 95% CI 0.82-0.98, p = 0.02) in patients

PowerPoint Presentation · DSR with 95% CI Nearest neighbour average National average ...

PowerPoint Presentation · DSR with 95% CI Nearest neighbour average National average ...

National Cycling Participation Survey 2019Cycling participation over the past month has declined only marginally from 21.8% (95% CI: 20.6% 23.0%) in 2017 to 21.4% (95% CI: 20.3% -

National Cycling Participation Survey 2019Cycling participation over the past month has declined only marginally from 21.8% (95% CI: 20.6% 23.0%) in 2017 to 21.4% (95% CI: 20.3% -

Cite as: R. Bertrand et al., Science 10.1126/science.abd3850 (2020). · Publication date: 27 November 2020 4 Thermophilization Microclimatic debt Variable Mean 95% CI P Mean 95% CI

Cite as: R. Bertrand et al., Science 10.1126/science.abd3850 (2020). · Publication date: 27 November 2020 4 Thermophilization Microclimatic debt Variable Mean 95% CI P Mean 95% CI

Issue Tables: A Profile of Military Servicemembers and ... · National Center for Education Statistics Demographic characteristics Pct. 95% CI Pct. 95% CI Pct. 95% CI Total 100.0[†]

Issue Tables: A Profile of Military Servicemembers and ... · National Center for Education Statistics Demographic characteristics Pct. 95% CI Pct. 95% CI Pct. 95% CI Total 100.0[†]

A Survey of Issues in Consumer Credit Risk€¦ · lower (95% CI) upper (95% CI) portfolio default rate TE TIME Through-the-Cycle PD lower (95% CI) upper (95% CI) portfolio default

A Survey of Issues in Consumer Credit Risk€¦ · lower (95% CI) upper (95% CI) portfolio default rate TE TIME Through-the-Cycle PD lower (95% CI) upper (95% CI) portfolio default

Differential Site-Based Expression of Pentose Phosphate ...downloads.hindawi.com/journals/dm/2017/7062517.pdf(95%CI)months (95%CI)months (95%CI)months (95%CI)months (95%CI)months G6PDH

Differential Site-Based Expression of Pentose Phosphate ...downloads.hindawi.com/journals/dm/2017/7062517.pdf(95%CI)months (95%CI)months (95%CI)months (95%CI)months (95%CI)months G6PDH

Cancers Urologiques & Interprétation Essais Prospectifs...95% CI, 0.63 to 0.85; P

Cancers Urologiques & Interprétation Essais Prospectifs...95% CI, 0.63 to 0.85; P

Relative Risk 1.31.41.51.61.71.21.11.00.90.8 Therapy A Better Therapy B Better COMPASS 95% CI no worse than 1.5 TARGET 95% CI no worse than 1.47 ASSENT-2.

Relative Risk 1.31.41.51.61.71.21.11.00.90.8 Therapy A Better Therapy B Better COMPASS 95% CI no worse than 1.5 TARGET 95% CI no worse than 1.47 ASSENT-2.

Slow freezing, vitrification and ultra-rapid freezing of ......slow freezing (odds ratio (OR) = 1.55, 95% confidence interval (CI) = 1.03–2.32, OR = 1.82, 95% CI = 1.04–3.20 and

Slow freezing, vitrification and ultra-rapid freezing of ......slow freezing (odds ratio (OR) = 1.55, 95% confidence interval (CI) = 1.03–2.32, OR = 1.82, 95% CI = 1.04–3.20 and

Afr. J. Food Agric. Nutr. Dev . 2021; 21(4): 17907-17930 https ...0.53), length (95% CI: -4.08, -3.36), LAZ (95% CI: -1.93, -1.16) and WAZ (95% CI:-1.03, -0.54) at 3 months of age,

Afr. J. Food Agric. Nutr. Dev . 2021; 21(4): 17907-17930 https ...0.53), length (95% CI: -4.08, -3.36), LAZ (95% CI: -1.93, -1.16) and WAZ (95% CI:-1.03, -0.54) at 3 months of age,